[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ATE377593T1 - 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung - Google Patents

9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung

Info

Publication number
ATE377593T1
ATE377593T1 AT04789167T AT04789167T ATE377593T1 AT E377593 T1 ATE377593 T1 AT E377593T1 AT 04789167 T AT04789167 T AT 04789167T AT 04789167 T AT04789167 T AT 04789167T AT E377593 T1 ATE377593 T1 AT E377593T1
Authority
AT
Austria
Prior art keywords
group
alpha
hydroxyl
taxane
present
Prior art date
Application number
AT04789167T
Other languages
English (en)
Inventor
James Mcchesney
James Ferrara
Jan Zygmut
Original Assignee
Tapestry Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tapestry Pharmaceuticals Inc filed Critical Tapestry Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE377593T1 publication Critical patent/ATE377593T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT04789167T 2003-09-25 2004-09-27 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung ATE377593T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50668003P 2003-09-25 2003-09-25

Publications (1)

Publication Number Publication Date
ATE377593T1 true ATE377593T1 (de) 2007-11-15

Family

ID=34393186

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04789167T ATE377593T1 (de) 2003-09-25 2004-09-27 9,10-alpha,alpha-oh-taxananaloga und verfahren zu deren herstellung

Country Status (14)

Country Link
US (8) US7745650B2 (de)
EP (2) EP1785416A3 (de)
JP (5) JP4874102B2 (de)
CN (1) CN1886400A (de)
AT (1) ATE377593T1 (de)
AU (1) AU2004275881A1 (de)
CA (1) CA2539975C (de)
DE (1) DE602004009943T2 (de)
DK (1) DK1664033T3 (de)
ES (1) ES2295937T3 (de)
HR (1) HRP20080057T3 (de)
PL (1) PL1664033T3 (de)
PT (1) PT1664033E (de)
WO (1) WO2005030150A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1785416A3 (de) 2003-09-25 2007-05-30 Tapestry Pharmaceuticals, Inc. 9, 10-Alpha, Alpha-OH-Taxan-Analogen und Herstellungsverfahren dafür
US7754850B2 (en) 2005-02-11 2010-07-13 University Of Southern California Chimeric disintegrin domain
US20100069643A1 (en) * 2005-12-21 2010-03-18 Mcchesney James D Convergent Process for the Synthesis of Taxane Derivatives
CN101370798A (zh) * 2005-12-21 2009-02-18 挂毯药品公司 用于形成紫杉烷的新化合物和方法及其应用
US20090306400A1 (en) * 2006-03-27 2009-12-10 Henri John T Convergent process for the synthesis of taxane derivatives.
EP2029156A4 (de) * 2006-05-01 2010-07-21 Univ Southern California Kombinationstherapie zur krebsbehandlung
EP2029563A4 (de) * 2006-06-12 2009-12-02 Canada Inc 6570763 Halbsynthetische route zur herstellung von paclitaxel, docetaxel und 10-deacetylbaccatin iii aus 9-dihydro-13-acetylbaccatin iii
US7847111B2 (en) 2006-06-19 2010-12-07 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
US11786504B2 (en) 2006-09-28 2023-10-17 Tapestry Pharmaceuticals, Inc. Taxane analogs for the treatment of brain cancer
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
US11873308B2 (en) 2006-11-06 2024-01-16 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008109360A1 (en) * 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
US8802394B2 (en) 2008-11-13 2014-08-12 Radu O. Minea Method of expressing proteins with disulfide bridges with enhanced yields and activity
US9227983B2 (en) 2011-04-07 2016-01-05 Arbor Therapeutics, LLC Taxane and abeo-taxane analogs
CN103764138A (zh) * 2011-04-07 2014-04-30 阿伯疗法责任有限公司 紫杉烷和Abeo-紫杉烷类似物
JP5621071B2 (ja) * 2011-06-06 2014-11-05 アーバー・セラピューティクス・リミテッド・ライアビリティ・カンパニーＡｒｂｏｒ Ｔｈｅｒａｐｅｕｔｉｃｓ，ＬＬＣ 癌化学療法薬の酸に不安定で親油性のプロドラッグ

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
EP0639186B1 (de) 1992-04-17 1999-06-23 Abbott Laboratories Taxol-derivate
FR2697019B1 (fr) 1992-10-15 1994-11-25 Rhone Poulenc Rorer Sa Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
ATE249826T1 (de) * 1992-11-13 2003-10-15 Univ Florida State Isobutenyl-substituierte taxane und deren pharmazeutische zusammensetzungen
WO1994020088A1 (en) * 1993-03-05 1994-09-15 Florida State University C9 taxane derivatives and pharmaceutical compositions containing them
AU689770B2 (en) * 1993-03-05 1998-04-09 Florida State University Process for the preparation of 9-desoxotaxanes
US6710191B2 (en) * 1993-03-05 2004-03-23 Florida State University 9β-hydroxytetracyclic taxanes
DK1228759T3 (da) * 1993-03-22 2005-04-18 Univ Florida State Farmaceutiske præparater indeholdende en taxan med en furyl- eller thienylsubstitueret sidekæde
FR2707293A1 (fr) 1993-07-08 1995-01-13 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2715846A1 (fr) * 1994-02-07 1995-08-11 Rhone Poulenc Rorer Sa Nouvelle composition pharmceutique à base de taxoïdes.
IT1275936B1 (it) 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5739359A (en) 1997-01-24 1998-04-14 Virginia Tech Intellectual Properties, Inc. Methods for preparing 1-deoxy paclitaxels
US6048990A (en) * 1998-05-01 2000-04-11 Napro Biotherapeutics, Inc. Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position
KR20020002488A (ko) * 2000-02-02 2002-01-09 플로리다 스테이트 유니버시티 리서치 파운데이션, 인크 항종양제로서 ｃ10 헤테로치환된 아세테이트 탁산
AR030188A1 (es) * 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
EP1383492A4 (de) 2001-03-23 2008-12-24 Napro Biotherapeutics Inc Molekulare konjugate zur verwendung in der krebstherapie
CA2354471A1 (en) 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
BR0215184A (pt) 2001-12-20 2006-06-06 Bristol Myers Squibb Co composições farmacêuticas de derivados de taxano oralmente ativos tendo biodisponibilidade aumentada
US6898834B1 (en) * 2003-03-03 2005-05-31 Westbridge Pty Ltd Barrel stave reclaim
EP1785416A3 (de) * 2003-09-25 2007-05-30 Tapestry Pharmaceuticals, Inc. 9, 10-Alpha, Alpha-OH-Taxan-Analogen und Herstellungsverfahren dafür
EP1894921A3 (de) 2003-09-25 2008-03-12 Tapestry Pharmaceuticals, Inc. 9, 10-Alpha, Alpha-OH-Taxan-Analoga und Herstellungsverfahren dafür
KR20080030564A (ko) 2005-05-12 2008-04-04 태피스트리 파마슈티컬스 인코퍼레이티드 표적 컨쥬게이트에 적합한 분자 구조물
CN101370798A (zh) 2005-12-21 2009-02-18 挂毯药品公司 用于形成紫杉烷的新化合物和方法及其应用
US20100069643A1 (en) 2005-12-21 2010-03-18 Mcchesney James D Convergent Process for the Synthesis of Taxane Derivatives
US20090306400A1 (en) 2006-03-27 2009-12-10 Henri John T Convergent process for the synthesis of taxane derivatives.
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008109360A1 (en) 2007-02-28 2008-09-12 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
US20080207743A1 (en) 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment

Also Published As

Publication number Publication date
DK1664033T3 (da) 2008-03-25
JP6216417B2 (ja) 2017-10-18
WO2005030150A3 (en) 2005-07-14
JP5629632B2 (ja) 2014-11-26
JP4874102B2 (ja) 2012-02-15
US20200237708A1 (en) 2020-07-30
DE602004009943D1 (de) 2007-12-20
JP2011137045A (ja) 2011-07-14
CA2539975A1 (en) 2005-04-07
JP2016180006A (ja) 2016-10-13
US20100324128A1 (en) 2010-12-23
EP1664033A2 (de) 2006-06-07
WO2005030150A2 (en) 2005-04-07
US20180125811A1 (en) 2018-05-10
US10238621B2 (en) 2019-03-26
HRP20080057T3 (en) 2008-02-29
US10639293B2 (en) 2020-05-05
US20050148657A1 (en) 2005-07-07
EP1785416A3 (de) 2007-05-30
EP1664033B1 (de) 2007-11-07
JP2011012070A (ja) 2011-01-20
PL1664033T3 (pl) 2008-04-30
PT1664033E (pt) 2008-01-17
JP5525394B2 (ja) 2014-06-18
JP6106634B2 (ja) 2017-04-05
AU2004275881A1 (en) 2005-04-07
JP2014196345A (ja) 2014-10-16
CN1886400A (zh) 2006-12-27
US8962870B2 (en) 2015-02-24
US20150133536A1 (en) 2015-05-14
EP1664033A4 (de) 2006-09-13
JP2007506792A (ja) 2007-03-22
US9820962B2 (en) 2017-11-21
DE602004009943T2 (de) 2008-08-28
US20160331718A1 (en) 2016-11-17
US20120077871A1 (en) 2012-03-29
US7879904B2 (en) 2011-02-01
US20190142784A1 (en) 2019-05-16
ES2295937T3 (es) 2008-04-16
US7745650B2 (en) 2010-06-29
US9402824B2 (en) 2016-08-02
CA2539975C (en) 2012-11-20
EP1785416A2 (de) 2007-05-16

Similar Documents

Publication Publication Date Title
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
ATE556085T1 (de) Phosphoramiditverbindung und verfahren zur herstellung von oligo-rna
DE60124692D1 (de) Verfahren zur herstellung von optisch-aktiven sulfoxid-derivaten
ATE438605T1 (de) Fluorverbindung, flourpolymer und verfahren zur herstellung davon
DE50308114D1 (de) Verfahren zur herstellung von 6-alkoxy-(6h)-dibenz(c,e)(1,2)-oxaphosphorinen
DE60327571D1 (de) Verfahren zur Herstellung von Polymerverbindungen durch Eliminierungsreaktion
WO2003031499A3 (de) Photochemisch und/oder thermisch strukturierbare harze auf silanbasis, einstufiges verfahren zu deren herstellung, dabei einsetzbare ausgangsverbindungen und herstellungsverfahren für diese
ATE536875T1 (de) Verfahren und zwischenzusammensetzungen zur herstellung von statinen, insbesondere rosuvastatin
ATE527270T1 (de) Herstellung von organosilanestern
ATE372332T1 (de) Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga
DE69616719D1 (de) Verfahren zur herstellung von taxol und seiner derivate
EP1810968A3 (de) 9, 10-a, a-OH-Taxan-Analoge und Herstellungsverfahren dafür
ATE310735T1 (de) Verfahren zur herstellung von spirocyclischen tetronsäurederivaten
DE60017151D1 (de) Verfahren zur reinigung fluorierter hydroxylverbindungen
ATE444323T1 (de) Neuartige epoxidverbindungen und verfahren zu ihrer herstellung
ATE325159T1 (de) Verfahren zur herstellung von synergistischen stabilisatorgemischen
DE602005025497D1 (de) Verfahren zur herstellung von halogensubstituiertem benzoldimethanol
ATE553081T1 (de) Verfahren zur herstellung einer bakteriziden pyridinverbindung, und bakterizide pyridinverbindung
DE602004020050D1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
DE602004030091D1 (de) Verfahren zur reduktiven deshalogenierung
ATE387421T1 (de) Verfahren zur herstellung von michael-addukten
ATE473989T1 (de) Eine phosphorylcholingruppe enthaltende verbindung, und verfahren zu ihrer herstellung
DE01924282T1 (de) Verfahren zur herstellung von taxanderivaten
HK1114084A1 (en) Method for producing thiocarbamate derivative
BRPI0412505A (pt) processo para preparar organohidrogensiloxanos cìclicos

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1664033

Country of ref document: EP

REN Ceased due to non-payment of the annual fee